Seizures Clinical Trials

Find Seizures Clinical Trials Near You

Implementazione di Algoritmi di Intelligenza Artificiale Nello Studio Delle RMN Cerebrali di Pazienti Con Epilessia / Implementation of Artificial Intelligence Algorithms for the Analysis of Brain MRI Scans in Patients With Epilepsy

Status: Recruiting
Location: See all (23) locations...
Study Type: Observational
SUMMARY

This study will test computer programs that help doctors read brain MRI scans. The programs use artificial intelligence (AI). The study includes people with epilepsy, a condition that causes repeated seizures. Brain changes linked to epilepsy can be hard to see on an MRI (magnetic resonance imaging) scan. Different doctors may read the same scan in different ways. The researchers want to build AI tools that help doctors find these changes earlier. Earlier findings could lead to a faster diagnosis. They could also help doctors decide if a genetic test or a brain surgery evaluation is right for a patient. The researchers also want to learn if AI can predict how well epilepsy surgery will work. If it can, surgeons could use the tool to plan an operation. The goal is to stop seizures while protecting parts of the brain that control speech and sight. Who can take part? People with epilepsy who are treated at the Gaslini Institute or another study center Adults who give their own written consent Children whose parent or caregiver gives written consent People who do not agree to take part cannot be included. What will happen? The researchers will collect brain MRI scans from about 2,000 people. The scans come from regular clinical care. The researchers will replace each person's name on the scan with a code number. The coded scans go to a secure online portal. Study centers around the world share this portal. One trained researcher will run the AI programs on the scans. The researchers will keep the scans for 2 years to build an image library. The researchers will compare the scans with health information. They want to find signs in the scans that show how epilepsy may change over time. This study does not test a new medicine or treatment. It will last about 2 years.

Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: f
View:

• \- Informed consent signed

Locations
United States
California
University of California
RECRUITING
Oakland
Washington, D.c.
George Washington University
RECRUITING
Washington D.c.
Illinois
Rush Hospital
RECRUITING
Chicago
Maryland
National Institute of Health (NINDS-Intramural)
RECRUITING
Bethesda
Pennsylvania
University of Pennsylvania
RECRUITING
Philadelphia
South Carolina
Medical University of South Carolina
RECRUITING
Charleston
Other Locations
Australia
The Florey Institute of Neuroscience and Mental Health
RECRUITING
Melbourne
Belgium
Université Libre de Bruxelles
RECRUITING
Brussels
Brazil
University of Campinas
RECRUITING
Campinas
Canada
Multimodal Imaging and Connectome Analysis Laboratory (Montreal Neurological Institute and Hospital, McGill University)
RECRUITING
Montreal
China
Nanjing University
RECRUITING
Nanjing
Germany
University Hospital Bonn
RECRUITING
Bonn
Italy
University of Cagliari
RECRUITING
Cagliari
University of Catanzaro
RECRUITING
Catanzaro
Istituto di Tecnologie Avanzate Biomediche, University D'Annunzio
RECRUITING
Chieti
IRCCS Istituto Giannina Gaslini
RECRUITING
Genova
University of Messina
RECRUITING
Messina
University of Modena and Reggio Emilia
RECRUITING
Modena
Mexico
Autonomous University of Mexico
RECRUITING
Mexico City
South Africa
University of Cape Town
RECRUITING
Cape Town
Spain
Institut d'Investigacions Biomèdiques August Pi i Sunyer
RECRUITING
Barcelona
Switzerland
University Hospital Zurich
RECRUITING
Zurich
United Kingdom
University College of London
RECRUITING
London
Contact Information
Primary
Pasquale Striano, MD
pasqualestriano@gaslini.org
+39 010 5636 2912
Time Frame
Start Date: 2023-05-30
Estimated Completion Date: 2026-12-31
Participants
Target number of participants: 2000
Treatments
People with epilepsy
Related Therapeutic Areas
Sponsors
Leads: Istituto Giannina Gaslini

This content was sourced from clinicaltrials.gov